# Empiric Therapy of Mucopurulent Cervicitis (MPC)

> **NCT01072136** · PHASE3 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 87 (actual)

## Conditions studied

- Vaginitis Bacterial
- Cervicitis

## Interventions

- **OTHER:** Placebo
- **DRUG:** Azithromycin
- **DRUG:** Cefixime

## Key facts

- **NCT ID:** NCT01072136
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-03
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2014-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01072136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01072136, "Empiric Therapy of Mucopurulent Cervicitis (MPC)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01072136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*